Home / Business and Economy / Bayer Wins Roundup Cancer Trial Amid Settlement Talks
Bayer Wins Roundup Cancer Trial Amid Settlement Talks
30 Oct
Summary
- Bayer secured a trial victory against three women claiming Roundup caused cancer.
- This verdict impacts the viability of future Roundup lawsuits post-Supreme Court ruling.
- Bayer is pursuing a $7.25 billion settlement for other outstanding Roundup cases.
Bayer achieved a trial victory on Thursday against three women who alleged their use of Roundup weedkiller led to cancer. This trial's outcome is crucial for the future of Roundup litigation, especially after a recent Supreme Court decision narrowed the scope of claims that plaintiffs can pursue.
The verdict in St. Louis, Missouri, favored Bayer-owned Monsanto. This ruling comes as Bayer is simultaneously seeking approval for a $7.25 billion settlement designed to address tens of thousands of other pending Roundup lawsuits, a proposal currently under examination by a Missouri state court judge.
Bayer stated the verdict underscores the difficulty plaintiffs will face in proving their cases after the Supreme Court's ruling. The company maintains that decades of studies confirm glyphosate, Roundup's active ingredient, is safe and does not cause cancer. However, approximately 65,000 claims remain in US courts from individuals who assert they developed cancer after using the product.
